We excitedly read the article about the close relationship of myocardial bridging (MB) and atherosclerosis at its proximal segment, which was suggested by Hong et al. (1), published in Anatolian J Cardiol 2014; 14: 40-7. They had suggested that the presence of MB on a coronary artery was one of the clinically independent risk factors for atherosclerosis, such as age, diabetes, and dyslipidemia. Duygu et al. (2) previously stated that MB initiated and facilitated the development and progression of atherosclerosis in the Anatolian Journal of Cardiology in 2007 (2). Systolic compression, which is a diagnostic marker for the presence of MB on the coronary angiogram, is generally supposed to account for the hemodynamic and endothelial changes that promote the atherosclerosis. In fact, the hemodynamic abnormalities are induced by MB during the diastolic period, in which the coronary artery flow and the myocardial perfusion are at their maximum (3). Since the MB behaves as an anatomic obstacle that surrounds and limits the coronary artery from its outside, a diastolic flow gradient develops at the proximal part of the bridged arterial segment. So, the diastolic gradient exerts a "seeding effect" that urges the cellular and lipid component of blood to pass into the sub-endothelial layers of the coronary artery. Phagocytic cells, cholesterol, and lipoprotein particles are the main components of an atherosclerotic plaque and also determine the vulnerability of the plaque (4). Moreover, the diastolic gradient at the proximal segment induces an increased shear stress and endothelial dysfunction, which are represented by reduced nitric oxide synthesis, antithrombotic functions, and vasodilation. These are the initial and earliest abnormalities observed in the development of atherosclerotic plaque (AP).
